Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP)
Clinical trial NCT03866798 · TERMINATED
Trial details
- NCT number
- NCT03866798
- Sponsor
- Octapharma
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-21
- Primary completion
- 2023-09-19
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.